In addition, the Toll-like Receptor signalling pathway, also linked to the IBC gene expression signature (Van Laere et al, 2005), leads to the activation of NF-κB, a hallmark of IBC (Van Laere et al, 2006b). Here, NFKB1 is linked to inflammatory breast carcinoma.